Surmodics gets IDE approval for drug-coated balloon; Adherium heralds data for its asthma-treating Smartinhaler;

> Surmodics ($SRDX) picked up the FDA's IDE approval for an early feasibility study of its SurVeil drug-coated balloon. Release

> Adherium presented new data on its Smartinhaler that showed increased adherence and a reduction in severe asthma attacks. Release